Oxaliplatin: all 947 studies that test it

Page 6 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.

• Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract CancerStatus unknownNCT02527824Phase 2
• Study of Oxaliplatin, Irinotecan, and S-1 in Gastric CancerCompletedNCT02527785Phase 2
• Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) CancerStatus unknownNCT02512380Phase 3
• Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the EsophagusActive, not recruitingNCT02509286Phase 3
• Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
• TOF Versus SOX in Metastatic Gastric CancerCompletedNCT02442362Phase 2/3
• RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCCStatus unknownNCT02426450Phase 2
• Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer PatientsStatus unknownNCT02415829Phase 2
• Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular CarcinomaStatus unknownNCT02403544Phase 1
• A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon CancerStatus unknownNCT02402972Phase 3
• A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and IrinotecanCompletedNCT02387138Phase 1
• Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver MetastasisStatus unknownNCT02380131Phase 4
• OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaCompletedNCT02368860Phase 1
• Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early StageTerminatedNCT02359162Phase 3
• XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based ChemotherapyStatus unknownNCT02350686Phase 2
• Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal CancerCompletedNCT02347904Phase 1
• Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver MetastasisWithdrawnNCT02345746Phase 2
• Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric CancerStatus unknownNCT02289378Phase 2
• CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer PatientsActive, not recruitingNCT02288195Phase 3
• RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Status unknownNCT02280070Phase 2
• Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal CancerCompletedNCT02244632Phase 1/2
• Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT02244489Phase 1
• S-1/Oxaliplatin for High Risk Patients Who Underwent GastrectomyTerminatedNCT02191566Phase 2
• Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive LymphomasCompletedNCT02181218Phase 1
• Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas CarcinomaCompletedNCT02172976Phase 2/3
• Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1WithdrawnNCT02129322Phase 2
• Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRMSuspendedNCT02121405Phase 3
• Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerCompletedNCT02114359Phase 3
• A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWithdrawnNCT02105350Phase 1
• PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESCompletedNCT02086656Phase 2
• Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNCT02077998Early Phase 1
• Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node MetastasisCompletedNCT02071043Phase 2
• Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon CarcinomaCompletedNCT02062749Phase 1
• Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawnNCT02046538Phase 2
• The Maintenance Therapy of Capecitabine of Advanced Gastric CancerStatus unknownNCT02038621Phase 2
• Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.CompletedNCT02035072Phase 2
• Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
• Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
• Borderline Pancreas Study: FOLFIRINOX +SBRTCompletedNCT01992705Early Phase 1
• Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric CancerStatus unknownNCT01980407Phase 2
• Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal CancerStatus unknownNCT01972503Phase 4
• Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver MetastasisStatus unknownNCT01962376Phase 4
• Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver MetastasesStatus unknownNCT01959061Phase 4
• A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric CancerTerminatedNCT01946061Phase 2
• Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal AdenocarcinomaCompletedNCT01932580Phase 2
• Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
• Avastin+ GemAOD As First-Line Treatment in NK/T Cell LymphomaStatus unknownNCT01921790Phase 2
• Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon CancerCompletedNCT01918527Phase 3
• D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric CarcinomaCompletedNCT01882933Phase 3
• Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT TumorsTerminatedNCT01858662Phase 2
• Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.CompletedNCT01858649Phase 2
• S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsCompletedNCT01824459Phase 3
• Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver MetastasesStatus unknownNCT01802645Phase 2
• Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric CancerStatus unknownNCT01795027Phase 3
• Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialStatus unknownNCT01761461Phase 3
• Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolTerminatedNCT01760252Phase 2
• A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompletedNCT01748773Phase 2
• A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal CancerStatus unknownNCT01732380Phase 2
• NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
• Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal CancerStatus unknownNCT01716949Phase 1/2
• Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal CancerTerminatedNCT01715363Phase 2
• A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 SurgeryStatus unknownNCT01679340Phase 2
• S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric CancerCompletedNCT01671449Phase 3
• Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTerminatedNCT01665274Phase 2
• Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
• Second Look Laparoscopy in Colorectal CancerStatus unknownNCT01628211Phase 2
• A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas CancerStatus unknownNCT01586611Phase 3
• SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric CancerStatus unknownNCT01583361Phase 3
• Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasCompletedNCT01572324Phase 2
• Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second RelapseCompletedNCT01562990Phase 1/2
• Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLCompletedNCT01562977Phase 2
• Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
• Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic AdenocarcinomaCompletedNCT01558869Phase 2
• Oxaliplatin for Children With Solid TumorsStatus unknownNCT01558453Phase 2
• Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
• Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric AdenocarcinomaStatus unknownNCT01552980Phase 2
• SOX as Adjuvant Chemotherapy for Resectable Gastric CancerStatus unknownNCT01542294Phase 1/2
• Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive LymphomasCompletedNCT01538641Phase 2
• Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially ResectableTerminatedNCT01531712Phase 2
• The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric CancerCompletedNCT01531452Phase 2
• Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2
• Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective TrialStatus unknownNCT01528826Phase 2
• Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic CholangiocarcinomaTerminatedNCT01525069Phase 1
• Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1WithdrawnNCT01524575Phase 2
• PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor MalignanciesStatus unknownNCT01522989Phase 1
• Perioperative Chemotherapy for Potentially Resectable Gastric CancerCompletedNCT01516944Phase 2/3
• Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid TumorStatus unknownNCT01511146Phase 2
• Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic CancerCompletedNCT01505413Phase 2
• Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
• A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
• Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01494363Phase 2
• LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerCompletedNCT01485744Phase 1
• A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian CarcinomaCompletedNCT01481701Phase 2
• Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
• Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum MetastasisStatus unknownNCT01471132Phase 2
• Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract CarcinomaStatus unknownNCT01470443Phase 3
• Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell CarcinomaStatus unknownNCT01467921Phase 2
• Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful NeuropathyCompletedNCT01450163Phase 3
• Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic MetastasesCompletedNCT01442935Phase 2
• Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01429961Phase 2

← Oxaliplatin overview